Nitric oxide-mediated apoptosis in human breast cancer cells requires changes in mitochondrial functions and is independent of CD95 (APO-1/Fas).

  • Authors:
    • V Umansky
    • A Ushmorov
    • F Ratter
    • K Chlichlia
    • M Bucur
    • A Lichtenauer
    • M Rocha
  • View Affiliations

  • Published online on: January 1, 2000     https://doi.org/10.3892/ijo.16.1.109
  • Pages: 109-126
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

We have previously shown that nitric oxide (NO) induces apoptosis in different human neoplastic lymphoid cells through caspase activation. Here we studied the NO-mediated apoptosis in human breast cancer cell lines derived from primary tumor (BT-20) or from metastasis (MCF-7). NO donor glycerol trinitrate (GTN) induced apoptosis in both cell lines which was completely abrogated after pretreatment with the broad spectrum caspase inhibitor zVAD-fmk. NO triggered also a time-dependent activation of caspase-1, caspase-3, and caspase-6 in these cells. Moreover, NO caused a release of mitochondrial protein cytochrome c into the cytosol, an increase in the number of cells with low mitochondrial transmembrane potential and with high level of reactive oxygen species production. However, NO did not induce mRNA expression of CD95 (APO-1/Fas) ligand. FAS-associated phosphatase-1 (FAP-1) molecule was constitutively expressed at the mRNA level and did not show any changes upon NO treatment in both breast cancer cell lines. The expression of the pro-apoptotic protein Bax and of the anti-apoptotic protein Bcl-2 remained unchanged in MCF-7 and BT-20 cells upon GTN treatment. We suggest that the mechanism of NO-mediated activation of the caspase cascade and subsequent apoptosis in human breast cancer cells required mitochondrial damage (in particular, cytochrome c release, disruption of mitochondrial transmembrane potential and generation of reactive oxygen species) but not the activation of the CD95/CD95L pathway.

Related Articles

Journal Cover

Jan 2000
Volume 16 Issue 1

Print ISSN: 1019-6439
Online ISSN:1791-2423

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Umansky V, Ushmorov A, Ratter F, Chlichlia K, Bucur M, Lichtenauer A and Rocha M: Nitric oxide-mediated apoptosis in human breast cancer cells requires changes in mitochondrial functions and is independent of CD95 (APO-1/Fas).. Int J Oncol 16: 109-126, 2000
APA
Umansky, V., Ushmorov, A., Ratter, F., Chlichlia, K., Bucur, M., Lichtenauer, A., & Rocha, M. (2000). Nitric oxide-mediated apoptosis in human breast cancer cells requires changes in mitochondrial functions and is independent of CD95 (APO-1/Fas).. International Journal of Oncology, 16, 109-126. https://doi.org/10.3892/ijo.16.1.109
MLA
Umansky, V., Ushmorov, A., Ratter, F., Chlichlia, K., Bucur, M., Lichtenauer, A., Rocha, M."Nitric oxide-mediated apoptosis in human breast cancer cells requires changes in mitochondrial functions and is independent of CD95 (APO-1/Fas).". International Journal of Oncology 16.1 (2000): 109-126.
Chicago
Umansky, V., Ushmorov, A., Ratter, F., Chlichlia, K., Bucur, M., Lichtenauer, A., Rocha, M."Nitric oxide-mediated apoptosis in human breast cancer cells requires changes in mitochondrial functions and is independent of CD95 (APO-1/Fas).". International Journal of Oncology 16, no. 1 (2000): 109-126. https://doi.org/10.3892/ijo.16.1.109